Articles by Randall C Willis

Preclinical in-vivo imaging opens new windows on disease

When it comes to the challenges of reproducibility in research these days, we all stand to suffer if we don’t address some of the systemic issues opening the door to rot

As applications broaden, footprints shrink

As if human diversity wasn’t tricky enough

Life sciences in general, and pharma/biotech along with it, moves fast, and our hats are off to the researchers who are trying to keep pace

Lessons from first-generation biologics inform the evolution of the next

There is certainly value to finding ways to alleviate some of the most challenging and debilitating aspects of autism, but DDNews Features Editor Randall C Willis offers a suggestion: Maybe we shouldn't be trying to actually 'cure' autism per se

Will embracing complexity lead to safer drugs?

Companies may need to share preclinical data with investors, the trade press and the like, but perhaps sharing a lot less of that early-stage data with the general public would be a good idea

Gene-based and stem cell-based therapies look for synergies

Maybe it's time for the federal government to get into the business of funding (and perhaps even spearheading) antibiotic discovery and development, since this is an area where the free market seems to be falling short

Is improved understanding of glycobiology the secret to improved biologics?